Vemurafenib: an unusual <scp>UVA</scp>‐induced photosensitivity
Vemurafenib is a new-targeted therapy approved for the treatment of patients with V600E BRAF-mutant metastatic melanoma. Among the cutaneous adverse events reported, the photosensitivity is frequently experienced. We aimed to characterize more deeply the mechanism leading to this photosensitivity as...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Carta |
| Language: | English |
| Published: |
2013
|
| Online Access: | https://doi.org/10.1111/exd.12119 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/exd.12119 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|